Stockreport

Evaxion Biotech A/S (NASDAQ:EVAX): Is Breakeven Near? [Yahoo! Finance]

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. With the latest financial year loss of US$2 [Read more]